Omega Therapeutics, Inc.
OMGADelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850838
Omega Therapeutics, Inc. was delisted in 2025; its insiders filed their last Form 4 on Dec 5, 2024; 53 institutions reported holding it in 13F filings for Q4 2024, worth $35.3M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Omega Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Omega Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Mehrotra Ravi | Director | – | Dec 5, 2024 | 0 |
| Nelson Jennifer Ann | Chief Scientific Officer | – | Nov 26, 2024 | 0 |
| Certel Kaan | See Remarks | – | Nov 15, 2024 | 0 |
| Rosiello Robert L. | Director | – | Oct 4, 2024 | 0 |
| Schade Christian S | Director | – | Jun 21, 2024 | 0 |
| Mendlein John | Director | – | Jun 21, 2024 | 0 |
| Kender Richard N | Director | – | Jun 21, 2024 | 0 |
| Szela Mary T | Director | – | Jun 21, 2024 | 0 |
| Young Richard A | Director | 739,118 | Jun 21, 2024 | 0 |
| Boehm Rainer J. | Director | – | Jun 21, 2024 | 0 |
| Levy Elliott M. | Director | – | Jun 21, 2024 | 0 |
| Werner Michelle C | Director | – | Jun 21, 2024 | 0 |
| Reed Joshua | Chief Financial Officer | – | Feb 9, 2024 | 0 |
| Zeng Ling | See Remarks | – | Feb 9, 2024 | 0 |
| McCauley Thomas | Chief Scientific Officer | – | Feb 9, 2024 | 0 |
| Karande Mahesh | President and CEO | 117,711 | Feb 9, 2024 | 0 |
| Moore Yan | Chief Medical Officer | – | Feb 9, 2024 | 0 |
| Beshar Luke M | Director | – | Jun 9, 2023 | 0 |
| Afeyan Noubar | Director, 10% Owner | 1,329,324Indirect | Jun 9, 2023 | 0 |
| McManus Kevin | Chief Human Resources Officer | – | Mar 2, 2023 | 0 |
| Flagship Pioneering, LLC | 10% Owner | 1,329,324Indirect | Feb 27, 2023 | 0 |
| Flagship Pioneering Special Opportunities Fund II, L.P. | 10% Owner | 1,329,324Indirect | Feb 27, 2023 | 0 |
| Flagship Pioneering Special Opportunities Fund II General Partner LLC | 10% Owner | 1,329,324Indirect | Feb 27, 2023 | 0 |
| Sawhney Roger | Chief Financial Officer | 2,941 | Mar 11, 2022 | 0 |
| Flagship Ventures Fund V, L.P. | 10% Owner | 1,617,646Indirect | Aug 5, 2021 | 0 |
| Flagship Ventures Fund V General Partner LLC | 10% Owner | 1,617,646Indirect | Aug 5, 2021 | 0 |
| Flagship V VentureLabs Rx Fund, L.P. | 10% Owner | 1,617,646Indirect | Aug 5, 2021 | 0 |
| Flagship VentureLabs V LLC | 10% Owner | 1,617,646Indirect | Aug 5, 2021 | 0 |
| Flagship VentureLabs V Manager LLC | 10% Owner | 1,617,646Indirect | Aug 5, 2021 | 0 |
| Flagship Pioneering Fund VI, L.P. | 10% Owner | 1,617,646Indirect | Aug 5, 2021 | 0 |
| Flagship Pioneering Fund VI General Partner LLC | 10% Owner | 1,617,646Indirect | Aug 5, 2021 | 0 |
| Nutritional Health LTP Fund General Partner LLC | 10% Owner | 1,617,646Indirect | Aug 5, 2021 | 0 |
| Nutritional Health LTP Fund, L.P. | 10% Owner | 1,617,646Indirect | Aug 5, 2021 | 0 |
| FPN General Partner LLC | 10% Owner | 1,617,646Indirect | Aug 5, 2021 | 0 |
| FPN, L.P. | 10% Owner | 1,617,646Indirect | Aug 5, 2021 | 0 |
| Artal Group S.A. | 10% Owner | 2,273,530 | Aug 3, 2021 | 0 |
| Artal International S.C.A. | 10% Owner | 2,273,530 | Aug 3, 2021 | 0 |
| Westend S.A. | 10% Owner | 2,273,530 | Aug 3, 2021 | 0 |
| Invus Public Equities Advisors, LLC | 10% Owner | 2,273,530 | Aug 3, 2021 | 0 |
| Invus Public Equities, L.P. | 10% Owner | 2,273,530 | Aug 3, 2021 | 0 |
| Stichting Administratiekantoor Westend | 10% Owner | 2,273,530 | Aug 3, 2021 | 0 |
| Artal International Management S.A. | 10% Owner | 2,273,530 | Aug 3, 2021 | 0 |
| Artal Treasury Ltd | 10% Owner | 2,273,530 | Aug 3, 2021 | 0 |
| Wittouck Amaury | 10% Owner | 2,273,530 | Aug 3, 2021 | 0 |
| Berry David A | Director | 53,082 | Aug 3, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 (view filing) | Jun 2 | 3 days | Young Richard ADirector | SSale | −5.00K | $8.00 | −$40.0K | −0.7%739.1K after | |
| May 3, 2023 (view filing) | May 1 | 2 days | Young Richard ADirector | SSale | −5.00K | $8.00 | −$40.0K | −0.7%744.1K after | 10b5-1 |
| Apr 10, 2023 (view filing) | Apr 6 | 4 days | Young Richard ADirector | SSale | −5.00K | $8.00 | −$40.0K | −0.7%749.1K after | 10b5-1 |
| Mar 20, 2023 (view filing) | Mar 17 | 3 days | Young Richard ADirector | SSale | −10.0K | $8.00 | −$80.0K | −1.3%754.1K after | |
| Feb 27, 2023 (view filing)5:20 PM ET | Feb 27 | Same day | Afeyan Noubar and 3 othersDirector, 10% Owner | PPurchase | +3.32M | $5.78 | +$19.2M | New position1.33M after | 2 lots |
| Jan 11, 2023 (view filing) | Jan 10 | 1 day | Young Richard ADirector | SSale | −20.0K | $8.00 | −$160.0K | −2.6%764.1K after | |
| Sep 15, 2022 (view filing) | Sep 14 | 1 day | Young Richard ADirector | SSale | −10.0K | $8.00 | −$80.0K | −1.3%784.1K after | |
| Aug 5, 2021 (view filing)5:43 PM ET | Aug 3 | 2 days | Flagship Pioneering, LLC and 5 others10% Owner | PPurchase | +1.18M | $17.00 | +$20.0M | +266.7%1.62M after | 3 lotsDuplicate filing |
| Aug 5, 2021 (view filing)5:41 PM ET | Aug 3 | 2 days | Afeyan Noubar and 9 othersDirector, 10% Owner | PPurchase | +1.18M | $17.00 | +$20.0M | +266.7%1.62M after | 3 lots |
| Aug 3, 2021 (view filing)5:16 PM ET | Jul 30-Aug 3 | 4 days | Artal Group S.A. and 8 others10% Owner | PPurchase | +950.0K | $16.93 | +$16.1M | +71.8%2.27M after | 2 lots |
| Aug 3, 2021 (view filing) | Aug 3 | Same day | Sawhney RogerChief Financial Officer | PPurchase | +2.94K | $17.00 | +$50.0K | New position2.94K after | |
| Aug 3, 2021 (view filing) | Aug 3 | Same day | Berry David ADirector | PPurchase | +53.1K | $17.00 | +$902.4K | New position53.1K after |